Covered recipient · General Payments record
CHARALAMBOS K RAMMOS
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$49,011.60
- Reported across 215 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,500.00 | 1 |
| Consulting Fee | $1,000.00 | 1 |
| Food and Beverage | $937.50 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MOTIVA USA, LLC | $2,500.00 | 2 |
| ABBVIE INC. | $419.06 | 21 |
| DAVOL INC. | $265.91 | 3 |
| REVANCE THERAPEUTICS, INC. | $198.72 | 6 |
| Mentor Worldwide LLC | $23.52 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.11 | 1 |
| Galderma Laboratories, L.P. | $14.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.84 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366954 | CMS |
| ABBVIE INC. | $17.40 | 03/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366958 | CMS |
| ABBVIE INC. | $15.04 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366961 | CMS |
| ABBVIE INC. | $9.16 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366965 | CMS |
| ABBVIE INC. | $15.51 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366969 | CMS |
| ABBVIE INC. | $5.28 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366974 | CMS |
| ABBVIE INC. | $1.00 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366978 | CMS |
| ABBVIE INC. | $18.32 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366982 | CMS |
| ABBVIE INC. | $15.01 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366986 | CMS |
| ABBVIE INC. | $58.12 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366990 | CMS |
| ABBVIE INC. | $6.16 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366994 | CMS |
| ABBVIE INC. | $20.16 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366998 | CMS |
| ABBVIE INC. | $12.99 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367001 | CMS |
| ABBVIE INC. | $21.39 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367005 | CMS |
| ABBVIE INC. | $21.68 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367009 | CMS |
| ABBVIE INC. | $23.67 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367014 | CMS |
| ABBVIE INC. | $12.45 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367018 | CMS |
| ABBVIE INC. | $15.51 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367022 | CMS |
| ABBVIE INC. | $10.26 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367026 | CMS |
| ABBVIE INC. | $91.55 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367030 | CMS |
| ABBVIE INC. | $16.56 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367034 | CMS |
| Davol Inc. | $74.19 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127660836 | CMS |
| Davol Inc. | $50.40 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127660840 | CMS |
| Davol Inc. | $141.32 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127660842 | CMS |
| Galderma Laboratories, L.P. | $14.18 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145322915 | CMS |
| Mentor Worldwide LLC | $23.52 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077612012 | CMS |
| MOTIVA USA, LLC | $1,000.00 | 11/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139154116 | CMS |
| MOTIVA USA, LLC | $1,500.00 | 11/24/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139156374 | CMS |
| REVANCE THERAPEUTICS, INC. | $6.95 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147927243 | CMS |
| REVANCE THERAPEUTICS, INC. | $18.16 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147927245 | CMS |
| REVANCE THERAPEUTICS, INC. | $1.98 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147927247 | CMS |
| REVANCE THERAPEUTICS, INC. | $102.42 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147927249 | CMS |
| REVANCE THERAPEUTICS, INC. | $64.85 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147927251 | CMS |
| REVANCE THERAPEUTICS, INC. | $4.36 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147927253 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.11 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105915524 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.